Two Sigma Advisers’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-67,300
Closed -$1.4M 2813
2022
Q2
$1.4M Sell
67,300
-206,400
-75% -$3.67M ﹤0.01% 1413
2022
Q1
$4.59M Sell
273,700
-23,400
-8% -$409K 0.01% 831
2021
Q4
$5.93M Buy
297,100
+251,700
+554% +$4.74M 0.01% 692
2021
Q3
$824K Buy
+45,400
New +$1.04M ﹤0.01% 1710
2021
Q2
Sell
-94,800
Closed -$2.84M 2779
2021
Q1
$2.84M Sell
94,800
-222,200
-70% -$7.58M 0.01% 1104
2020
Q4
$9.11M Sell
317,000
-192,900
-38% -$5.21M 0.02% 600
2020
Q3
$12.4M Sell
509,900
-270,600
-35% -$5.84M 0.04% 470
2020
Q2
$14M Sell
780,500
-84,100
-10% -$1.11M 0.04% 430
2020
Q1
$7.04M Buy
864,600
+56,700
+7% +$648K 0.03% 600
2019
Q4
$10.7M Buy
807,900
+759,100
+1,556% +$9.19M 0.02% 577
2019
Q3
$580K Buy
+48,800
New +$903K ﹤0.01% 1660

Other funds holding CVET

Two Sigma Advisers's CVET Position: Q3 2022 in Review

Two Sigma Advisers sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 67,300 shares — an estimated $1.4M sold.

Two Sigma Advisers first reported a position in CVET in Q3 2019 and held it in 11 quarters. The position peaked at $14M in Q2 2020. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Two Sigma Advisers reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 67,300 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $1.4M.
  • Two Sigma Advisers first reported a position in Covetrus, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Two Sigma Advisers's Covetrus, Inc. Common Stock position peaked at $14M in Q2 2020.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.